No Disease or Condition is Being Studied
10
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Caring for Dementia Caregivers in Ethnic Immigrant Communities
Optimizing Operational Parameters for Diagnostic Vitrectomy
Evaluation of the Performance and Safety of VACUSERA® PRP Tubes in the Preparation of Autologous Platelet-Rich Plasma
Role of the Noradrenergic System in the Regulation of Learning Dynamics: Evaluation of the Effect of a Low-dose Selective Noradrenaline Reuptake Inhibitor (NOISYXETINE)
ANI-Guided Fentanyl Infusion During Living Donor Liver Resections
Ergonomic Protocol for Competitive E-Sport Athletes
The Effects of Gyngerlean Supplementation on Energy Expenditure
Acute Psychological and Physiological Effects of Cannabigerol
Supporting Secondary School Student Wellbeing Through a Mobile App and Wearable Biofeedback
Evaluation of Virtual Reality in Hazmat Training